ArticleNature communications2025
Controlling crystallization in covalent organic frameworks to facilitate photocatalytic hydrogen production.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Polymorphism-Controlled Exciton Dissociation in Hydrogen-Bonded Organic Framework Photocatalysts.Angewandte Chemie (International ed. in English) · 2026Article
- Influence of Reactor Configuration and Operating Conditions on Nanostructured Semiconductor Photocatalysts for Hydrogen Evolution: A Systematic Technical Review.Nanomaterials (Basel, Switzerland) · 2026Review
- Amorphous-to-crystalline transformation: a mechanochemical pathway to imine-linked covalent organic frameworks.RSC mechanochemistry · 2026Article
- Tunable axial symmetry β-ketoamine covalent organic frameworks for efficient photocatalytic HChemical science · 2026Article
- Polarized dislocation covalent organic frameworks ignite hot electrons to propel photocatalytic hydrogen generation.Nature communications · 2026Article
- Defective three-dimensional covalent organic frameworks for enhanced hydrogen peroxide photosynthesis and organic transformation.Nature communications · 2026Article
- Molecular Diode-Based Covalent Organic Frameworks: Imine Orientation-Driven Acid-Base Switching Photocatalytic HAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- The Power of Catalytic Centers and Ascorbate in Boosting the Photocatalytic Hydrogen Evolution Performance of TpDTz 2D-COF.Journal of the American Chemical Society · 2026Article
- Enhanced piezo-photocatalytic water splitting activity via engineering robust dipole moments in covalent organic frameworks.Nature communications · 2025Article
- Dipole synergy enables fast directional charge transport for solar hydrogen and benzaldehyde coproduction.Nature communications · 2025Article
- Regulating Light Absorption, Charge Orientation, and Oxygen Activation of Conjugated Porous Polymers for Photocatalytic Organic Synthesis.Accounts of materials research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The catalytic performance, depending on the surface nature, is ubiquitous in photocatalysis. However, surface engineering for organic photocatalysts through structural modulation has long been neglected. Here, we propose a zone crystallization strategy for covalent organic frameworks (COFs) that enhances surface ordering through regulator-induced amorphous-to-crystalline transformation. Dynamic simulations show that attaching monofunctional regulators to the surface of spherical amorphous precursor improves surface dynamic reversibility, increasing crystallinity from the inside out. The resulting COF microspheres display surface-enhanced crystallinity and uniform spherical morphology. The visible photocatalytic hydrogen evolution rate reaches 126 mmol g
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.